Swissmed Secures Series A Investment
Swissmed Health Secures Multi-Million Dollar Series A Investment
Swissmed Health, formerly known as Swiss Biological Medicine Center, announced today that it has secured a multi-million-dollar funding “Growth Round” from international investors, including directly from members of Brookstreet Equity Partners LLP (“Brookstreet”). The funding will be used to expand the clinic’s services and facilities, enhance patient care and experience, and accelerate growth.
“We are thrilled to partner with Brookstreet,” said George Xydas, CEO of Swissmed Health. “This investment will enable us to take our patient care and experience to the next level, expand our services and facilities, and achieve our goal of becoming one of Europe’s top life-extension centers, helping people live longer and better.”
Swissmed Health is known for its personalized approach to healthcare, offering a range of medical services including longevity, cancer, autoimmune diseases, and more. The center’s team of highly trained and experienced doctors work together to address the root cause of patients’ health concerns, creating personalized treatment plans tailored to each patient’s unique needs.
“We believe that Swissmed Health is poised for significant growth, and we are excited to support the clinic’s vision and mission,” said Omiros D. Sarikas, CEO of Brookstreet Equity Partners. “We are confident that our investment will help the clinic expand its services and facilities, improve patient care and experience, and achieve its long-term goals.”
The funding from Brookstreet of London is a significant milestone for Swissmed Health, positioning the clinic for continued success and growth in the years to come. Swissmed Health was advised by KPMG for the transaction.
Whether you're seeking to optimize your current health status or proactively invest in your future well-being, Swissned Health is here to guide you every step of the way. Embark on a path to a healthier, longer life with Swissmed Health: The Home of Clinical Longevity.